A possible Guillain-Barré syndrome/transverse myelitis overlap syndrome after recent COVID-19
© BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
Neurological manifestations are common in SARS-CoV-2 infection, including life-threatening acute muscle weakness, due to neuromuscular disorders such as acute transverse myelitis (TM) and Guillain-Barré syndrome (GBS). These syndromes can rarely coexist and present as an overlap syndrome. Here, we report a patient who developed acute symmetrical proximal lower limb weakness 5 days after diagnosis of COVID-19. GBS was diagnosed due to the presence of motor signs, albumin-cytological dissociation in cerebrospinal fluid examination and axonal damage according to nerve condition tests. However, abnormal areas on MRI of the thoracic spine and lack of improvement with intravenous immunoglobulin supported a diagnosis of TM. Therefore, a possible overlap between GBS and TM was established. To our knowledge, this is the third case report of GBS/TM overlap syndrome after COVID-19. The patient's full and rapid recovery with intravenous corticosteroids and plasmapheresis supports our diagnosis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
BMJ case reports - 15(2022), 2 vom: 09. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Alrubaye, Riyadh [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 11.02.2022 Date Revised 23.02.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1136/bcr-2021-246967 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM336723644 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM336723644 | ||
003 | DE-627 | ||
005 | 20231225232805.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/bcr-2021-246967 |2 doi | |
028 | 5 | 2 | |a pubmed24n1122.xml |
035 | |a (DE-627)NLM336723644 | ||
035 | |a (NLM)35140089 | ||
035 | |a (PII)e246967 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Alrubaye, Riyadh |e verfasserin |4 aut | |
245 | 1 | 2 | |a A possible Guillain-Barré syndrome/transverse myelitis overlap syndrome after recent COVID-19 |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.02.2022 | ||
500 | |a Date Revised 23.02.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a Neurological manifestations are common in SARS-CoV-2 infection, including life-threatening acute muscle weakness, due to neuromuscular disorders such as acute transverse myelitis (TM) and Guillain-Barré syndrome (GBS). These syndromes can rarely coexist and present as an overlap syndrome. Here, we report a patient who developed acute symmetrical proximal lower limb weakness 5 days after diagnosis of COVID-19. GBS was diagnosed due to the presence of motor signs, albumin-cytological dissociation in cerebrospinal fluid examination and axonal damage according to nerve condition tests. However, abnormal areas on MRI of the thoracic spine and lack of improvement with intravenous immunoglobulin supported a diagnosis of TM. Therefore, a possible overlap between GBS and TM was established. To our knowledge, this is the third case report of GBS/TM overlap syndrome after COVID-19. The patient's full and rapid recovery with intravenous corticosteroids and plasmapheresis supports our diagnosis | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a infection (neurology) | |
650 | 4 | |a neuroimaging | |
650 | 4 | |a neuromuscular disease | |
650 | 4 | |a spinal cord | |
700 | 1 | |a Bondugula, Vijayamala |e verfasserin |4 aut | |
700 | 1 | |a Baleguli, Vidya |e verfasserin |4 aut | |
700 | 1 | |a Chofor, Rosemary |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMJ case reports |d 2008 |g 15(2022), 2 vom: 09. Feb. |w (DE-627)NLM209291001 |x 1757-790X |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2022 |g number:2 |g day:09 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/bcr-2021-246967 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2022 |e 2 |b 09 |c 02 |